When “certified” isn’t enough: the antibiotic shrimp crisis and why multi-residue testing matters

FDA import data for May 2026 reveals that 77.5% of antibiotic-contaminated shrimp refused entry to the US came from BAP-certified facilities. For food safety professionals, the message is clear: certification is not a substitute for rigorous testing.

A crisis hiding behind a certification stamp

Every month, the US Food and Drug Administration publish seafood import refusal data, and in 2026, the figures made for uncomfortable reading for the global aquaculture industry. In May alone, the FDA reported 94 seafood entry line refusals. Analysis of those refusals reveals that shrimp contaminated with banned veterinary drug residues were identified in shipments originating from Bangladesh, China, India, Ecuador, Thailand, and Vietnam.

What makes these numbers particularly striking is not just their scale, but their source. Across the first five months of 2026, 77.5% of shrimp shipments refused for banned antibiotics originated from processors certified under the Best Aquaculture Practices (BAP) programme, an independent third-party certification widely promoted as a mark of safe, responsible seafood production.

The primary drug detected in May refusals was nitrofurans, a class of antibiotics banned in aquaculture exports to the United States. Several processors associated with refusals are already subject to FDA Import Alert 16-129 “Detention Without Physical Examination” for nitrofurans contamination.

The drugs being detected, and why they matter

The antibiotics appearing in FDA refusal reports are not obscure compounds. Nitrofurans, chloramphenicol, and amoxicillin are well-established prohibited substances in aquaculture exports destined for major markets. Their continued detection, across multiple countries, multiple processors, and multiple certification statuses, signals a systemic failure in pre-export screening and farm-level controls.

Nitrofurans in particular have been linked to antimicrobial resistance (AMR) concerns, making their use in food animal production not just a regulatory violation but a broader public health issue. Scientists have also connected the use of banned antibiotics and fungicides in aquaculture to the development of drug-resistant pathogens, a risk that does not stop at the border of any single country.

Why certification alone cannot close the gap

The persistence of these violations in BAP-certified facilities raises a fundamental question about the role of third-party auditing in food safety. Audit-based certification was never designed to replace laboratory-based residue testing, yet in many supply chains, it has come to substitute for it. The FDA’s monthly refusal data is exposing the consequences of that gap.

Importers, retailers, and food producers who rely solely on certification as their assurance of residue-free product are exposed to significant regulatory, commercial, and reputational risk. In 2026, that risk is not theoretical; it is documented in the FDA’s own refusal database, month after month.

Where Randox Food Diagnostics fits in

Randox Food Diagnostics has developed multi-analyte screening platforms specifically designed to address the limitations of single-analyte testing in complex supply chains. Built on Biochip Array Technology, our platform, the Evidence Investigator, enables the simultaneous detection of multiple veterinary drug residues in a single test run.

For seafood and aquaculture applications, this means the ability to screen for nitrofurans, chloramphenicol, and a range of other banned substances from a single sample, reducing both the time and cost of comprehensive residue screening, while increasing the breadth of coverage.

In practical terms, our technology supports food businesses at every point in the supply chain: from processors and exporters conducting pre-shipment verification, to importers and testing laboratories serving the broader food industry.

The bottom line for food safety professionals

The May 2026 FDA data is a reminder that antibiotic contamination in seafood is not a solved problem. It is an active, evolving risk, affecting certified and uncertified facilities alike, across multiple producing countries, with real consequences for public health and trade compliance.

Comprehensive residue testing is not optional in this environment. It is the foundation on which meaningful food safety assurance is built.

Randox Food Diagnostics offers multi-residue screening solutions for veterinary drug residues in seafood and aquaculture samples. To find out how our platforms can support your food safety programme, visit randoxfood.com or contact our team by emailing info@randoxfooddiagnostics.com.

Reference: https://shorturl.at/LBehd